Previous Article | Next Article ![]()
Antimicrob. Agents Chemother., Nov 1997, 2456-2460, Vol 41, No. 11
S Quan, H Venter and ER Dabbs
Mycobacterium smegmatis inactivates rifampin by ribosylating this
antibiotic. The gene responsible for this ability was cloned and was shown
to confer low-level resistance to this antibiotic (MIC increase, about
12-fold) in related organisms. A 600-bp subclone responsible for
ribosylating activity and resistance carried an open reading frame of 429
bp. Targeted disruption of the gene in M. smegmatis resulted in mutants
with much increased susceptibility to rifampin (MICs of 1.5 instead of 20
microg/ml) as well as the loss of antibiotic-inactivating ability. Also,
disruption of this gene led to a much lower frequency of occurrence of
spontaneous high-level rifampin-resistant mutants.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic
Genetics Department, University of the Witwatersrand, Johannesburg, South Africa.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»